Candriam S.C.A. lessened its stake in Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 86.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 5,169 shares of the company's stock after selling 34,145 shares during the period. Candriam S.C.A.'s holdings in Molina Healthcare were worth $1,504,000 at the end of the most recent quarter.
A number of other large investors have also added to or reduced their stakes in MOH. True Wealth Design LLC grew its position in shares of Molina Healthcare by 2,500.0% during the 3rd quarter. True Wealth Design LLC now owns 104 shares of the company's stock valued at $36,000 after acquiring an additional 100 shares during the period. Versant Capital Management Inc increased its holdings in shares of Molina Healthcare by 83.1% in the 4th quarter. Versant Capital Management Inc now owns 163 shares of the company's stock worth $47,000 after buying an additional 74 shares during the last quarter. Wingate Wealth Advisors Inc. bought a new stake in shares of Molina Healthcare in the 4th quarter worth about $52,000. Financial Perspectives Inc bought a new stake in shares of Molina Healthcare in the 4th quarter worth about $59,000. Finally, Lindbrook Capital LLC grew its holdings in Molina Healthcare by 38.5% during the 4th quarter. Lindbrook Capital LLC now owns 205 shares of the company's stock valued at $60,000 after purchasing an additional 57 shares during the last quarter. Institutional investors own 98.50% of the company's stock.
Insider Activity
In other Molina Healthcare news, Director Steven J. Orlando sold 1,000 shares of the company's stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $301.33, for a total transaction of $301,330.00. Following the completion of the sale, the director now owns 17,375 shares of the company's stock, valued at $5,235,608.75. This represents a 5.44 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 1.11% of the stock is owned by corporate insiders.
Molina Healthcare Stock Performance
MOH stock traded down $4.47 during trading on Thursday, hitting $310.50. 803,166 shares of the company's stock traded hands, compared to its average volume of 774,761. The company has a quick ratio of 1.62, a current ratio of 1.62 and a debt-to-equity ratio of 0.69. Molina Healthcare, Inc. has a 52 week low of $262.32 and a 52 week high of $423.92. The stock has a fifty day moving average price of $297.31 and a two-hundred day moving average price of $311.20. The stock has a market capitalization of $17.23 billion, a price-to-earnings ratio of 15.20, a price-to-earnings-growth ratio of 1.06 and a beta of 0.56.
Molina Healthcare (NYSE:MOH - Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $5.05 earnings per share for the quarter, missing the consensus estimate of $5.74 by ($0.69). Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. As a group, equities analysts anticipate that Molina Healthcare, Inc. will post 24.4 EPS for the current fiscal year.
Analysts Set New Price Targets
A number of equities analysts have commented on MOH shares. JPMorgan Chase & Co. restated a "neutral" rating and issued a $350.00 target price (down from $378.00) on shares of Molina Healthcare in a research note on Tuesday, December 17th. Mizuho decreased their price target on shares of Molina Healthcare from $382.00 to $376.00 and set an "outperform" rating for the company in a report on Monday, March 3rd. Wells Fargo & Company raised shares of Molina Healthcare from an "equal weight" rating to an "overweight" rating and raised their price target for the stock from $295.00 to $372.00 in a report on Wednesday, March 5th. StockNews.com lowered shares of Molina Healthcare from a "buy" rating to a "hold" rating in a research note on Monday. Finally, Stephens restated an "equal weight" rating and set a $345.00 price target on shares of Molina Healthcare in a research report on Thursday, February 6th. One research analyst has rated the stock with a sell rating, seven have given a hold rating, six have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $355.69.
Read Our Latest Stock Report on Molina Healthcare
Molina Healthcare Company Profile
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Recommended Stories

Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.